functions from Alzheimer's, but know

ing that the disease has taken hold can

help patients plan for when they will be

e debilitated by the condition, Apo:

ays. It’s also important to be ready

liable and sensitive blood test

ent breakthroughs do
‘occur, since blood can be a useful way
to monitor how well patients respond to
those therapies.

Blood testing holds similar pores
tial for people with rheumatoid art
(RA), an immune-triggered disorder that
causes painful inflammation in the Joints
and can severely restrict movement. Tra-
ditional blood tests for inflammation—a
hallmark characteristic of RA and other
autoimmune diseases—aren't especially
helpful, since inflammatory markers can
also be a sign that the patient has a cold
‘orgome other condition the immune sys-
tem js fighting

Scientists at Crescendo science,
a San Francisco company developing a
jnumbetiof blood-based diagnostics for

diseases, have developed a test that

| Jooks at a dozen blood markers for RA
B i and can rank paticnts’ inflammation as
‘mild, moderate or severe. This is criti-

cal because treating early inflammation
is key to preserving joints and prevent-
ing more serious damage, which can re-

it

tolo
with
for when tr

in disability and a lifelong reliance
on side-effect-heavy prescription druss
or multiple surgeries or both. <

area of research. Researchers foresee
‘a day when an athletic coach could as-
sess a player's head injury in real time.
‘Team doctors could draw blood to de-
termine if it’s safe for the player to get
back in the game. Experts are looking at
total tau and SNTF, for example—two
proteins that tend to spike in thehour or

1906

The tist 4
ood tent

for syphilis,
called the
Wassermann
test, is
developed box:

ging
diabetes

MOAN raAuma ls another, peoega

Testing blood
Without a
needle

‘There’® Bood news for needle-
ghoble pationts: sctontists are
'$c0vering other. teas invasive
to seo what's Boing on
fe the body —Walne tosh,
Such as ght, lasers and Rng,
Optics without drawing blogg
Researchers are now taking,
advantage of growin
‘bout how compounds ko
‘Elucose absorb wavelengths
Of infrared light, for instance,
‘and using lasers to read them.
‘A'team at Princeton found a
‘way to shine boams on people's
aims to get a rolativaly
Becurate reading of thelr

to holp treat disease. Photo-
dynamic therapy relles on a drug
that can be “activated” when
‘exposed to specific wavelengths
(of lint, making It ideal for
treating tumors on the surtace of
ongane or those on the skin.
Finally, borrowing from the

world of miniature electronics,
researchers are devising ways

to use ultrafine glass or plastic
fiber optics to provide constant
feedback on body readings, from
things as simple as temperature
to the presence of blood gases:
Such as oxygen, carbon dioxide
and more.

Ht may not be long before:

‘needles will be a thing of the
Past—for some tests, anyway.

s0 after a concussion. Studies show that
Peak levels of total tau correlate with
how many days the person experiences
symptoms such as dizziness, nausea and
memory problems, And SNTF may be
‘a good barometer for serious structural
damage to the brain. It was tested in
small number of head-injury patients at
Houston hospitals in 2013. Compared
with a healthy group of controls, the pa-
tients who had elevated SNTF had cog-
nitive issues that persisted for months
after the blow.
About 20% of patients with brain ip-
Juries experience continual deficits in
‘Winging and other functions. 1¢ blood
tests can help identify this minority, it
Could mean the difference between early
treatment and serious problems that de-
Velop and worsen over time.

All of this begs the question: How
much do you really want to know? This
is something patients will soon confront
as they are offered theoption of knowing
their future risk of cancer, Alzheimer's or
other conditions. Forsomeic :nay be wel-
come information, whileforothers it may
bring only uncertainty and anxiety

Most researchers say the prospects
for better care make the ‘growth of blood
testing both inevitable and worthwhile.

Ie isn't just the benefit to individual pa=

tients. If a blood test can help reveal
whetheradrugis working, for instance, it
‘can lead to more effective care for every-
fone. “We can start to understand why
some patients don't respond to conven
tional treatments” says Dr. Chad Mirkin,

a professor ofcchemistry at Northwestern
University who developed the so-called
liquid biopsy that lights up when cancer
cells are present.

‘There's no question our blood
to tell us about our health—we ee =
togetbetterat reading what it has to say.

Today
for some z
diseases

from a single
